K-Ras (G12C) inhibitor-12, an oncogenic K-Ras(G12C) inhibitor, which was essential to sustain T cell infiltration in reaction to immune checkpoint inhibitor in a pro-inflammatory manner, has provided benefits for cancer patients (53). Here, KRAS is linked to cancer.